Literature DB >> 17483619

[Pavlik's method in developmental dysplasia of the hip].

Viktor Bialik1.   

Abstract

One of the worst complications following treatment of developmental dysplasia of the hip is avascular necrosis. In the first half of the 20th century, the incidence of this problem reached up to 30% of treated children. To avoid this complication, Arnold Pavlik developed a new method in the late 1940s and called it a dynamic approach to treatment, which was based on the ingenious idea that the hip is an organ of movements and needs movement to be healed. Healing is accomplished by using stirrups as an aid to attaining flexion of the hips and knees, whereby the child achieves a normal hip nonviolently by himself. Pavlik's method spread slowly throughout the world and this literature review points out problems with this method, and summarizes the rates of success achieved and avascular necrosis reported by various authors.

Entities:  

Mesh:

Year:  2007        PMID: 17483619

Source DB:  PubMed          Journal:  Acta Orthop Traumatol Turc        ISSN: 1017-995X            Impact factor:   1.511


  4 in total

1.  Success of Pavlik Harness Treatment Decreases in Patients ≥ 4 Months and in Ultrasonographically Dislocated Hips in Developmental Dysplasia of the Hip.

Authors:  Hakan Ömeroğlu; Nusret Köse; Anil Akceylan
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

2.  Treatment of the Developmental Dysplasia of the Hip with an Abduction Brace in Children up to 6 Months Old.

Authors:  Raphaël Wahlen; Pierre-Yves Zambelli
Journal:  Adv Orthop       Date:  2015-02-26

3.  Treatment of developmental dysplasia of the hip with the Pavlik harness in children under six months of age: indications, results and failures.

Authors:  H Ömeroglu
Journal:  J Child Orthop       Date:  2018-08-01       Impact factor: 1.548

4.  Comparison of treatment outcomes of stable and unstable developmental dysplasia of the hip with the Tübingen splint.

Authors:  Emmelie Chaibi; Claire-Anne Saugy; Eleftheria Samara; Pierre-Yves Zambelli; Sophie Rosa Merckaert
Journal:  Front Pediatr       Date:  2022-08-25       Impact factor: 3.569

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.